Meriwether Wealth & Planning’s Gilead Sciences GILD Stock Holding History

Meriwether Wealth & Planning’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$34.7K	Buy	+233	New	+$32.7K	0.02%	296

Other funds holding GILD

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Meriwether Wealth & Planning's GILD Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Gilead Sciences (GILD) in Q3 2026: 233 shares worth $34.7K. The stake represents 0.02% of the portfolio and ranks #296 among its holdings.

1,878 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

Meriwether Wealth & Planning held 233 shares of Gilead Sciences worth $34.7K as of Q3 2026.
Gilead Sciences was a new Meriwether Wealth & Planning position in Q3 2026.
Gilead Sciences made up 0.02% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #296 holding.
1,878 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.